L'échange gratuit au péril de la commercialisation = The free exchange in peril of commercial activitiesLEBEAU, A.Météorologie (Paris. 1925). 1995, Num 9, pp 71-83, issn 0026-1181Article

Sparsame Modifikation des kommerziellen Ciclosporin-Radioimmunoassay = Modification économique de la ciclosporine commerciale dans des dosages radioimmunologiques = Economical modification of the commercialy available ciclosporine in radioimmunoassayLAMPE, D; PRÜMKE, H.-J; HÜLLER, H et al.Pharmazie. 1988, Vol 43, Num 1, issn 0031-7144, 4Article

Creating smaller eyedrops by reducing eyedropper tip dimensionsBROWN, R. H; HOTCHKISS, M. L; DAVIS, E. B et al.American journal of ophthalmology. 1985, Vol 99, Num 4, pp 460-464, issn 0002-9394Article

Commercial CAPTAIN systemISOZAKI, K.Japan Telecommunications Review. 1983, Vol 25, Num 4, pp 246-254, issn 0021-4744Article

Determination of the structure of a synthetic impurity in guaifenesin: modification of a high-performance liquid chromatographic method for phenylephrine hydrochloride, phenylpropanolamine hydrochloride, guaifenesin, and sodium benzoate in dosage formsSCHIEFFER, G. W; SMITH, W. O; LUBEY, G. S et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 12, pp 1856-1858, issn 0022-3549Article

Isomeric purity and supersaturation of iopamidolDAWSON, P; PITFIELD, J; SKINNEMOEN, K et al.British journal of radiology. 1983, Vol 56, Num 670, pp 711-713, issn 0007-1285Article

Problems with generic theophylline and indiscriminate brand switchingKLEIN, G. L.Annals of allergy. 1987, Vol 58, Num 5, pp 350-352, issn 0003-4738Article

Allergenic extracts: characterization, standardization, and prospects for the futureYUNGINGER, J. W.The Pediatric clinics of North America. 1983, Vol 30, Num 5, pp 795-805, issn 0031-3955Article

Gas chromatography assay of atropine in formulations containing atropine sulphate and cholinesterase reactivatorsBRIGGS, C. J; SIMONS, K. J.Journal of chromatography. 1983, Vol 257, Num 1, pp 132-136, issn 0021-9673Article

The bioavailability of three dipyridamole productsMARKIEWICZ, A; HARTLEB, M; BOLDYS, H et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1983, Vol 21, Num 10, pp 499-501, issn 0174-4879Article

AESGP 19th annual meeting, Stockholm, June 8-10, 1983Association européenne des spécialités pharmaceutiques grand public. Annual meeting. 19. 1983, 36 p.Conference Proceedings

Bioequivalence studies for veterinary drug productsRHODES, C. T.Clinical research and regulatory affairs. 1992, Vol 9, Num 1, pp 1-9Article

Fatty acid compositions of the lipids obtained from commercial salmon productsOTA, T; SASAKI, S; ABE, T et al.Nippon Suisan Gakkaishi. 1990, Vol 56, Num 2, pp 323-327, issn 0021-5392Article

Pyrethrin poisoning from commercial-strength flea and tick sprayPATON, D. L; WALKER, J. S.The American journal of emergency medicine. 1988, Vol 6, Num 3, pp 232-235, issn 0735-6757Article

On the contamination of commercially available aprotinins with pancreatic islet peptidesBALDISSERA, F. G. A; HOLST, J. J.Scandinavian journal of clinical & laboratory investigation. 1984, Vol 44, Num 7, pp 669-672, issn 0036-5513Article

Problems in the measurement of zinc using heparin as an anticoagulantGERVIN, C. A; GERVIN, A. S; NICHOLS, W et al.Life sciences (1973). 1983, Vol 33, Num 26, pp 2643-2649, issn 0024-3205Article

Confusion entre noms commerciaux : entretenue par les agences du médicament = Confusion between commercial names : maintained by drug agenciesLa Revue Prescrire. 2007, Vol 27, Num 290, pp 941-944, issn 0247-7750, 4 p.Article

Eigenschaften hineinkonstruiert = Preparation-integrated propertiesPlastverarbeiter. 1997, Vol 48, Num 9, pp 62-63, issn 0032-1338Article

Nouveaux médicaments : Principes actifs entrant dans la composition de spécialités pharmaceutiques commercialisées en 1996 = A survey of some new drugsOSLET, J.Journal de pharmacie de Belgique. 1997, Vol 52, Num 1, pp 28-40, issn 0047-2166Article

Sorption und oxidative Veränderungen von 3-Butylhydroxyanisol (3-BHA) in SiO₂-Dispersionen. 2. Mitt: Stabilität von 3-BHA in Sorbaten handelsüblicher SiO₂-Präparate = Adsorption et oxydation du 3-BHA dans les dispersions de silice = Adsorption and oxidative alterations of 3-butylhydroxyanisole (3-BHA) in silica dispersionsTISCHINGER-WAGNER, H; RUPPRECHT, H.Pharmazeutische Industrie. 1984, Vol 46, Num 10, pp 1056-1062, issn 0031-711XArticle

DuPont Dow Elastomers enrichit sa gamme Viton = DuPont Dow Elastomers enlarges its Viton rangeCaoutchoucs & plastiques (Paris). 2001, Num 800, pp 54-56, issn 1154-1105Article

Flixotide : Generic Name : Fluticasone propionateMALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 2, pp 65-66, issn 0311-905XArticle

Analysis of thianaphthene in commercial naphthaleneMCKAGUE, A. B; MEIER, H. P.Journal of chromatography. 1984, Vol 299, Num 2, pp 487-488, issn 0021-9673Article

ANTIBODY RESPONSES IN MAN AFTER SINGLE OR REPEATED TREATMENT WITH INTRAMUSCULAR AMPICILLINAHLSTEDT S; HUITFELDT B; MAESEN F et al.1981; INT. ARCH. ALLERGY APPL. IMMUNOL.; ISSN 0020-5915; CHE; DA. 1981; VOL. 66; NO 4; PP. 382-390; BIBL. 22 REF.Article

ANALYSE COMMERCIALE: REFLEXIONS SUR LA PROCEDURE DE L'ECART PARTAGEABLEGY P.1983; ANALUSIS; ISSN 0365-4877; FRA; DA. 1983; VOL. 11; NO 6; PP. 257-262; ABS. ENG; BIBL. 4 REF.Article